AB
BNTC icon

Amalgamated Bank’s Benitec Biopharma BNTC Stock Holding History

Amalgamated Bank’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-467
Closed -$6K – 1788
2025
Q4 		$6K Sell
467
-27
-5% -$373 ﹤0.01% 2624
2025
Q3 		$7K Hold
494
– – ﹤0.01% 2591
2025
Q2 		$6K Buy
+494
New +$6.91K ﹤0.01% 2631

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Amalgamated Bank's BNTC Position: Q1 2026 in Review

Amalgamated Bank sold out of Benitec Biopharma (BNTC) in Q1 2026, closing a stake of 467 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in BNTC in Q2 2025 and held it in 3 quarters. The position peaked at $7K in Q3 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Amalgamated Bank reported no remaining Benitec Biopharma position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 467 Benitec Biopharma shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Benitec Biopharma in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Benitec Biopharma position peaked at $7K in Q3 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.